Epilepsy Foundation

Epilepsy Foundation Texas Receives $2 Million Gift from the Yield Giving Open Call

Retrieved on: 
Wednesday, March 20, 2024

HOUSTON, March 20, 2024 (GLOBE NEWSWIRE) -- Today, MacKenzie Scott’s Yield Giving announced Epilepsy Foundation Texas as one of the Yield Giving Open Call’s awardees working with people and in places experiencing the greatest need in the United States.

Key Points: 
  • HOUSTON, March 20, 2024 (GLOBE NEWSWIRE) -- Today, MacKenzie Scott’s Yield Giving announced Epilepsy Foundation Texas as one of the Yield Giving Open Call’s awardees working with people and in places experiencing the greatest need in the United States.
  • Epilepsy Foundation Texas received a $2 million unrestricted grant to further its mission.
  • "On behalf of the entire Epilepsy Foundation Texas community, I am profoundly grateful for the extraordinary $2 million gift from MacKenzie Scott’s Yield Giving,” said Kurt Baxter, CEO of EFTX.
  • More info on Epilepsy Foundation Texas: www.eftx.org
    More info on the Yield Giving Open Call: www.leverforchange.org
    More info on Yield Giving Foundation: www.yieldgiving.com

Epilepsy Foundation Texas to Host Annual Epilepsy Walks at the Dallas Zoo, April 20 and the Ft. Worth Zoo, April 27

Retrieved on: 
Wednesday, March 20, 2024

HOUSTON, March 20, 2024 (GLOBE NEWSWIRE) -- Epilepsy Foundation Texas (EFTX) is hosting its annual Texas Epilepsy Walk at two locations in the DFW area including the Dallas Zoo on Saturday, April 20 and the Fort Worth Zoo on Saturday, April 27.

Key Points: 
  • HOUSTON, March 20, 2024 (GLOBE NEWSWIRE) -- Epilepsy Foundation Texas (EFTX) is hosting its annual Texas Epilepsy Walk at two locations in the DFW area including the Dallas Zoo on Saturday, April 20 and the Fort Worth Zoo on Saturday, April 27.
  • The Texas Epilepsy Walk is a family-friendly event that offers:
    Entrance into the Dallas Zoo or Ft. Worth Zoo
    A chance to connect and encourage: Meet other families affected by epilepsy, share stories, and build community.
  • The Texas Epilepsy Walk - Dallas will begin the registration process at the entrance of the Dallas Zoo at 7:30 am.
  • EFTX’s Annual Texas Epilepsy Walk is great event for families to support a great cause and enjoy a fun day at the Zoo.

Epilepsy Foundation Partners with Iaso Ventures to Launch the NeuroImpact Fund

Retrieved on: 
Wednesday, March 20, 2024

BOWIE, Md., March 20, 2024 /PRNewswire/ -- Today, the Epilepsy Foundation announced a transformative partnership with Iaso Ventures, a prominent venture capital firm, to establish the Iaso NeuroImpact Fund. This innovative fund serves as a cornerstone for advancing the development of pioneering therapeutics, diagnostics, and technologies aimed at revolutionizing the landscape of care for epilepsy and seizure disorders. Leveraging the professional investment acumen of Iaso Ventures and the profound research and clinical expertise of the Epilepsy Foundation, the NeuroImpact Fund is poised to catalyze breakthroughs in epilepsy treatment and support.

Key Points: 
  • Venture Philanthropy Fund to Support Development of New Therapeutics, Diagnostics and Technologies
    BOWIE, Md., March 20, 2024 /PRNewswire/ -- Today, the Epilepsy Foundation announced a transformative partnership with Iaso Ventures, a prominent venture capital firm, to establish the Iaso NeuroImpact Fund.
  • Leveraging the professional investment acumen of Iaso Ventures and the profound research and clinical expertise of the Epilepsy Foundation, the NeuroImpact Fund is poised to catalyze breakthroughs in epilepsy treatment and support.
  • "Throughout history, the Epilepsy Foundation has been at the forefront of supporting early-stage companies developing innovative solutions for epilepsy," said Bernice Martin Lee, chief executive officer, Epilepsy Foundation.
  • Companies funded through the Iaso NeuroImpact Fund hold the promise to redefine epilepsy treatment paradigms with the most cutting-edge approaches.

Recognizing when someone is having a seizure – and how you can help during those first critical moments

Retrieved on: 
Wednesday, February 14, 2024

But experiencing a seizure does not always mean a person has epilepsy.

Key Points: 
  • But experiencing a seizure does not always mean a person has epilepsy.
  • Seizures can be provoked by acute head injuries, alcohol withdrawal and high blood sugar, among other things.

What does a seizure look like?

  • For some people, their seizure is a purely internal sensation.
  • In fact, most people with epilepsy have only relatively subtle, nonconvulsive seizures at first, then develop convulsive seizures over time.
  • This is the type of seizure most of us are familiar with, probably because it’s the kind most frequently depicted, though not always accurately, in movies and on television.
  • The most common type of epileptic seizure are those that are focal – that is, they arise from a confined region of the brain.

What causes a seizure to occur?


Seizures are the result of abnormal electrical activity in the brain. The bursts of activity disrupt normal functioning and initiate hyperactivity in the affected brain area, which then can affect the corresponding body part. For instance, if the seizure arises from the part of the brain involved in arm movement, that arm will experience involuntary hyperactivity.

If you’re a bystander, how can you help?

  • Many seizure-related injuries occur due to falling or coming in contact with sharp or hard objects.
  • If they begin to fall, help them to the floor as gently as possible and put something soft under their head.
  • During the convulsive phase of a seizure, breathing may be intermittent.
  • So turn the person on their side so they can breathe more easily and lower the risk of aspiration.
  • Following the seizure, and as the person gradually recovers and wakes up, help them sit up in a safe space.

Are new treatments available?

  • People with epilepsy, particularly those who experience frequent seizures, will often have emergency medications in their possession.
  • The most common emergency medications – also called seizure rescue medications – are a type of anticonvulsants called benzodiazepines.
  • Patients and their caretakers may have access to rescue medications and know how to use them.

What if it’s not a seizure?


If a bystander does not witness a seizure, but instead finds someone unresponsive or minimally responsive, call 911. They may be suffering from other medical issues, such as a drug overdose. And if you are interested in training and certification for seizure first aid, or if you simply want to know more, the Epilepsy Foundation has more information.

  • Jacob Pellinen has received research support from the Department of Neurology at the University of Colorado School of Medicine, the Colorado Clinical and Translational Sciences Institute, NIH/NINDS, and the American Epilepsy Society.
  • J. Pellinen serves as chair of the professional advisory board for the Epilepsy Foundation of Colorado and Wyoming (unpaid), serves as the Epilepsy Section Editor for Current Neurology and Neuroscience Reports, and has received compensation for serving on the scientific advisory board for SK Life Science.

Minyard Morris Announces Janani S. Rana as First Female Partner

Retrieved on: 
Thursday, February 1, 2024

NEWPORT BEACH, Calif., Feb. 1, 2024 /PRNewswire-PRWeb/ -- Janani S. Rana has been announced the sixth partner at Minyard Morris, a Newport Beach, California-based family law firm. Janani is the firm's first female partner, marking a significant stride in the distinguished firm's history. Janani is a Certified Family Law Specialist and experienced trial attorney who handles complex family law issues and high net worth matters.

Key Points: 
  • Janani is the firm's first female partner, marking a significant stride in the distinguished firm's history.
  • E. Minyard, Founding Partner, Minyard Morris
    "Janani has an ownership mentality, and she is interested in helping improve every aspect of the firm to benefit our clients and our people," said Mark.
  • E. Minyard, Founding Partner, Minyard Morris .
  • Janani joined Minyard Morris in 2016 after working in family law for seven years in Los Angeles County.

Empatica Announces Plans for Landmark Clinical Study to Develop an AI-Based Seizure Forecast Based on Wearable Real-World Data

Retrieved on: 
Thursday, November 30, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231130692933/en/
    Empatica announces plans to develop an AI-based seizure forecasting algorithm based on wearable real-world Data (Graphic: Business Wire)
    More than 3 million Americans suffer from epilepsy, according to numbers from the Centers for Disease Control.
  • And around one third of people with epilepsy have refractory epilepsy which occurs when medications no longer control seizures1.
  • We are excited to announce our plans to begin a large clinical study aimed at using wearable technology to enable reliable seizure forecasting,” said Dr. Rosalind Picard, Co-Founder and Chief Scientist at Empatica.
  • Individuals who are interested in being contacted for study participation when recruitment begins can visit empatica.com/seizure-forecasting to learn more.

VISIE™ Inc., Formerly Advanced Scanners, Raises $8.2M to Make the Unseen Seen in Orthopedic, Neuro, and Spine Surgery

Retrieved on: 
Thursday, November 30, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231130216508/en/
    VISIE is a 3D computer vision and spatial computing company developing deep tech optical scanners for use in robotic and navigated orthopedic, neuro, and spine surgery.
  • The company’s proprietary hardware and software produce snap registration and rich objective data that can be used in both image-dependent and imageless robotic, as well as navigated, surgery.
  • While VISIE’s first product promises to be in orthopedic surgery, the company is not slowing down on other applications.
  • They are designed to simplify surgical workflow and shave significant time off robotic and navigated surgery while simultaneously increasing surgical precision.

Congressional Briefing Calls for More Focus & Government Investment in the Epilepsies to Support the 3.4M People Living with the Epilepsies

Retrieved on: 
Monday, November 20, 2023

WASHINGTON, Nov. 20, 2023 /PRNewswire/ -- In cooperation with the Congressional Epilepsy Caucus, the Epilepsy Foundation, Epilepsies Action Network, CURE Epilepsy, Rare Epilepsy Network, DEE-P Connections, and other epilepsy organizations held a briefing on Capitol Hill to raise awareness about the epilepsies and urge Congress to prioritize epilepsy programs and research in the final Fiscal Year 2024 federal budget. The briefing also called for members of the U.S. House of Representatives to join the Congressional Epilepsy Caucus.

Key Points: 
  • The briefing also called for members of the U.S. House of Representatives to join the Congressional Epilepsy Caucus.
  • Congressional Briefing calls for more funding for epilepsy research, improved outcomes and access to care.
  • "I'm not only speaking as CEO, but also as a person living with epilepsy.
  • I have a son with epilepsy, so this is very important for me and everyone who struggles with epilepsy.

Laura Weidner Assumes New Role as Chief Advocacy & Government Relations Officer at the Epilepsy Foundation

Retrieved on: 
Monday, October 30, 2023

BOWIE, Md., Oct. 30, 2023 /PRNewswire/ -- The Epilepsy Foundation today announced that Laura Weidner, Esq., has been promoted to Chief Advocacy and Government Relations Officer for her ongoing work to elevate advocacy for the 3.4 million people — and their families — in the U.S. living with the epilepsies. Since she joined the Foundation in 2018 as vice president of Government Relations & Advocacy, Weidner has spearheaded the organization's strategy on federal and state-level policy, as well as legal advocacy and grassroots engagement. In this new role, she will build on those efforts to improve access to care, end epilepsy-related discrimination, promote public health and education, and fuel research through advocacy efforts.

Key Points: 
  • Since she joined the Foundation in 2018 as vice president of Government Relations & Advocacy, Weidner has spearheaded the organization's strategy on federal and state-level policy, as well as legal advocacy and grassroots engagement.
  • In this new role, she will build on those efforts to improve access to care, end epilepsy-related discrimination, promote public health and education, and fuel research through advocacy efforts.
  • "Since joining the Epilepsy Foundation, Laura has embodied the essence of our mission by advocating for policies that effect systemic change and address challenges that come with living with epilepsy," said Bernice Martin Lee, Chief Executive Officer, Epilepsy Foundation.
  • Before that, she worked in government affairs at the Child Welfare League of America for three years.

SK Biopharmaceuticals Assembles 'Board of Prominent Experts' to Boost Growth, Innovation

Retrieved on: 
Thursday, August 3, 2023

SEOUL, South Korea, Aug. 2, 2023 /PRNewswire/ -- SK Biopharmaceuticals, a global biotech company, announced the formation of its Scientific Advisory Board (SAB), comprising of five prominent experts in oncology, epilepsy, and radiopharmaceutical therapy.

Key Points: 
  • ; and Il Minn, Ph.D., a radiopharmaceutical and theranostics expert; and Cheol-Young Maeng, Ph.D., a biopharmaceutical industry expert.
  • "The Board will work closely with SK Biopharmaceuticals to drive innovation, and further improve patient care and outcomes as the envisioned biotech company."
  • SK Biopharmaceuticals Chief Executive Officer Donghoon Lee said, "We believe the Board will provide SK Biopharmaceuticals profound insights to help the company make faster decision, transform, and navigate uncertainty.
  • He served as the CTO of SK Biopharmaceuticals in 2021.